Abstract
This chapter interrogates how assumptions about biomedical HIV prevention configure social factors as largely secondary to effectiveness, either as barriers to rollout and uptake of treatment as prevention (TasP), or as the pliable conduits for the same processes. They also gloss over the reflexivity of people who are the subjects of biomedical HIV prevention, ignoring the often unanticipated effects it may have in their social and sexual lives. Like previous approaches to HIV prevention, a biomedical approach needs to engage with the limitations inherent in the assumptions it makes and view itself as open to modification. In doing so, there may be value in understanding biomedical HIV prevention as an assemblage of biomedical, social and political forces and effects, each of which is necessary for it to effectively serve all who are in need of it.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
The interview fragments come from the Transformative HIV and Sexual Health Technologies project, funded by a Monash Research Accelerator Grant (2013–2014). Ethics approval for this project was granted by Monash University Human Research Ethics Committee.
References
Baral, S., Rao, A., Sullivan, P., Phaswana-Mafuya, N., Diouf, D., Millett, G., et al. (2019). The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment. The Lancet HIV, 6(9), e632–e638.
Boseley, S., & Devlin, H. (2019, May 2). End to AIDS in sight as huge study finds drugs stop HIV transmission. The Guardian. Retrieved May 9, 2019, from https://www.theguardian.com/society/2019/may/02/end-to-aids-in-sight-as-huge-study-finds-drugs-stop-hiv-transmission.
Brisson, J., & Nguyen, V. (2017). Science, technology, power and sex: PrEP and HIV-positive gay men in Paris. Culture Health & Sexuality, 19, 1066–1077.
Cohen, M. (2019). Successful treatment of HIV eliminates sexual transmission. The Lancet, 393, 2366–2367.
Davis, M. (2002). HIV prevention rationalities and serostatus in the risk narratives of gay men. Sexualities, 5, 281–299.
Davis, M., & Flowers, P. (2014). HIV/STI prevention technologies and strategic (in)visibilities. In M. Davis & L. Manderson (Eds.), Disclosure in health and illness (pp. 72–88). Abingdon: Routledge.
DeLanda, M. (2016). Assemblage theory. Edinburgh: Edinburgh University Press.
Elford, J., Bolding, G., & Sherr, L. (2002). High-risk sexual behaviour increase among London gay men between 1998 and 2001: What is the role of HIV optimism? AIDS, 16, 1–8.
Flowers, P. (2001). Gay men and HIV/AIDS risk management. Health, 5, 50–75.
Granich, R., Gilks, C., Dye, C., De Cock, K. M., & Williams, B. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for the elimination of HIV transmission: A mathematical model. The Lancet, 373, 48–57.
Kippax, S., & Race, K. (2003). Sustaining safe practice: Twenty years on. Social Science and Medicine, 57, 1–12.
Kippax, S., & Stephenson, N. (2012). Beyond the distinction between biomedical and social dimensions of HIV: Prevention through the lens of social public health. American Journal of Public Health, 102(5), 789–799.
Kippax, S., & Stephenson, N. (2016). Socialising the biomedical turn in HIV prevention. London: Anthem Press.
Kippax, S., Crawford, J., Davis, M., Rodden, P., & Dowsett, G. (1993). Sustaining safe sex: A longitudinal study of a sample of homosexual men. AIDS, 7, 257–263.
Lazarus, J. V., Safreed-Harmon, K., Barton, S. E., Costagliola, D., Dedes, N., & del Amo Valero, J. (2016). Beyond viral suppression of HIV – The new quality of life frontier. BMC Medicine, 14, 94.
Nguyen, V., O’Malley, J., & Pirkle, C. (2011). Remedicalizing an epidemic: From HIV treatment as prevention to HIV treatment is prevention. AIDS, 25, 1435–1441.
Nwokolo, N., Hill, A., McOwan, A., & Pozniak, A. (2017). Rapidly declining HIV infection in MSM in Central London. The Lancet HIV, 4, e482–e483.
Patton, C. (2011). Rights language and HIV treatment: Universal care or population control? Rhetoric Society Quarterly, 41, 250–266.
Persson, A. (2016). ‘The world has changed’: Pharmaceutical citizenship and the reimagining of serodiscordant sexuality among couples with mixed HIV status in Australia. Sociology of Health & Illness, 38, 380–395.
Robert, B., & Rosser, S. (1990). Evaluation of the efficacy of AIDS education interventions for homosexually active men. Health Education Research, 5, 299–308.
Robinson, S. (2011). Queensland labor and lesbian, gay, bisexual,transgender, intersex and queer policy. Queensland Review, 18, 207–215.
Rodger, A., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Degen, O., et al. (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive PARTNER taking suppressive antiretroviral therapy (PARTNER): Final results of a multicentre, prospective, observational study. The Lancet, 393, 2428–2438.
Squire, C. (2013). Living with HIV and ARVs: Three letter lives. Houndmills: Palgrave Macmillan.
UNAIDS. (2014). 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS.
van Doorn, N. (2012). Between hope and abandonment: Black queer collectivity and the affective labour of biomedicalised HIV prevention. Culture Health & Sexuality, 14, 827–840.
Watney, S. (2000). Imagine Hope: AIDS and gay identity. London: Routledge.
Young, I., Flowers, P., & McDaid, L. (2016). Can a pill prevent HIV? Negotiating the biomedicalisation of HIV prevention. Sociology of Health & Illness, 38, 411–425.
Acknowledgements
I am grateful for comments from Paul Flowers and Corinne Squire and the contributions made by interviewees. Research for this chapter was in part supported by a grant from the Monash University Research Accelerator Programme.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Davis, M. (2021). Making the Ideal Real: Biomedical HIV Prevention as Social Public Health. In: Bernays, S., Bourne, A., Kippax, S., Aggleton, P., Parker, R. (eds) Remaking HIV Prevention in the 21st Century. Social Aspects of HIV, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-030-69819-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-69819-5_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-69818-8
Online ISBN: 978-3-030-69819-5
eBook Packages: Social SciencesSocial Sciences (R0)